To analyse target volume variations during SIB-IMRT of squamous cell carcinoma of uterine cervix

Author(s):  
Qurat-ul-Ain Shamsi ◽  
Khalid Iqbal ◽  
Shagufta Jabeen ◽  
Saeed Ahmad Buzdar

Abstract Purpose: To assess volume variations in target site due to changes in bladder filling and rectal content including air bubbles during simultaneous-integrated boost intensity-modulated radiotherapy (SIB-IMRT) of patients suffering from squamous cell carcinoma of uterine cervix. Materials and methods: A total of ten patients of squamous cell carcinoma of uterine cervix were enrolled in this analysis. All patients were planned to undergo SIB-IMRT using 10 MV beam. Planning target volume of the tumour (PTVtumour) and PTVnodal were prescribed with 5,040 and 4,500 cGy doses, respectively. During planning, PTVtumour V95%, PTVnodal V95% and organs at risk (OARs) (bladder, rectum, femoral heads and small bowel) volumes were measured from initial CT planning scans taken with full bladder. CT scans were acquired once in a week over a treatment period of 5·5 weeks. Intra-treatment scans with full bladder were then fused with the planning scans to determine variations in the target volume and the OAR volume. Changes in radiation dose to the PTVtumour and the PTVnodal were also assessed by comparing intra-treatment scans with the planning (first) scans. Results: All patients showed intra-treatment bladder volume larger than the planning bladder volume. Difference between planning bladder and intra-treatment bladder volumes ranged from 4·5 to 49%. Rectal volume varied from 17 to 60 cc. A wide variation between planning and intra-treatment air volumes was found in most of the patients. When comparing initial and inter-fraction air volumes, the maximum difference was 366·67%. Due to bladder and rectal volume variations, PTVtumour V95% and PTVnodal V95% doses did not remain constant throughout the treatment. The maximum discrepancy between intra-treatment PTVtumour dose and planning PTVtumour dose was 12·15%. The maximum difference between planning and inter-fraction PTV V95% was 48·28%. PTVnodal dose observed from scan taken in last week of treatment was 12·87% less than planning PTVnodal dose analysed from planning CT scan. Maximum difference in planning and inter-fraction PTVnodal V95% was 57·78%. Conclusion: Inconsistent bladder and rectal volumes had a significant impact on target volume and dosage during an entire course of SIB-IMRT. For radiotherapy of gynaecological malignancies, data on variations in PTV should be acquired on daily basis to target radiation dose to the tumour site with accuracy.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e15504-e15504
Author(s):  
Bo Cheng ◽  
Xue Meng

e15504 Background: The correlation between the clinical target volume (CTV) margin and esophageal squamous cell carcinoma (ESCC) recurrence pattern is not completely clear. Our aim was to retrospectively evaluate the recurrence patterns in ESCC patients who received definitive radiotherapy (RT) with different CTVs, and determine the optimum longitudinalmargin. Methods: Patients with histologically proven ESCC (N = 134) were classified into the following three groups according to the initial expanding margin of CTV at the recurrence side: CTV1 with longitudinal margin ≥ 3cm (N = 73), CTV2 with 2-3cm (N = 37), and CTV3 with < 2cm (N = 24). The recurrence patterns were analyzed relative to the CTV margins, as well as the radiation dose, tumor stage, comorbidities etc. Results: The recurrence sites were significantly different between the CTV1 and CTV3 (p < 0.001), but not between the CTV1 and CTV2 groups (p = 0.052). In addition, 42 (91.3%) of the 46 patients that received low-dose (55-60Gy) RT showed recurrence at the site of the primary tumor, an obviously greater proportion compared to those who underwent a high-dose ( > 60Gy) treatment (77.3%, p = 0.018). Drinking was also a clear contributing factor (p = 0.025). Age, smoking, comorbidities,tumor location, stage and treatment mode were not significant prognostic factors for ESCC recurrence. Conclusions: CTV with a 2-3cm longitudinal expansion to the gross tumor volume (GTV) is acceptable for radical RT for ESCC, and recurrence at the primary tumor site is associated with low radiation dose ( < 60Gy).


2000 ◽  
Vol 10 (5) ◽  
pp. 358-365 ◽  
Author(s):  
J. B. Vermorken ◽  
C. Mangioni ◽  
S. Pecorelli ◽  
M. E. L. Van Der Burg ◽  
A. T. Van Oosterom ◽  
...  

2021 ◽  
pp. 106689692199713
Author(s):  
Jijgee Munkhdelger ◽  
Tomoko Shimooka ◽  
Yoshinori Koyama ◽  
Sadakatsu Ikeda ◽  
Yoshiki Mikami ◽  
...  

There is a lack of knowledge about molecular alterations in basaloid squamous cell carcinoma (BSCC) of the uterine cervix. A 72-year-old woman with a history of previous subtotal hysterectomy and current vaginal bleeding was referred to our hospital. Initially, adenoid cystic carcinoma (ACC) was diagnosed upon cervical cytology and biopsy. Chest imaging showed multiple metastatic lesions in both lungs. The surgical specimen showed BSCC with diffuse p16 immunoreactivity and negativity for S-100, c-kit, and neuroendocrine markers. There was a focal minor ACC component, which could have explained the previous cytology and biopsy diagnosis. Next-generation sequencing with two different panels showed coexisting PIK3CA mutation and NTRK2 fusion with 10 additional variants of unknown significance ( ATR, DAXX, FAM123B, JAK1, KEL, MLL2, NOTCH2, PALB2, POLD1, POLE). The MYB gene fusions were not identified. The patient received chemotherapy with TRK inhibitor larotrectinib and carboplatin, which caused shrinkage of metastatic lung nodules. This is the first report of cervical BSCC with extensive molecular workup, which detected multiple genetic events, including targetable ones, which are potentially implicated in the development of a tumor. The accumulation of data and further studies on this tumor are necessary to define its diagnostic criteria and its clinical and biological behavior.


2009 ◽  
Vol 24 (3) ◽  
pp. 542 ◽  
Author(s):  
Yong Soon Kwon ◽  
Yong Man Kim ◽  
Ga Won Choi ◽  
Young Tak Kim ◽  
Joo-Hyun Nam

Sign in / Sign up

Export Citation Format

Share Document